The more we know about our visitors, the easier it will be for us to publish everything you want to see.

Keep me logged in Forgot your password?

Please wait...

Please wait...

CYTOXAN INJECTION

Compare CYTOXAN INJECTION  to:
Compare
Compare

Generic Name for CYTOXAN INJECTION

Cyclophosphamide 500mg, 1g, 2g; per vial; pwd for inj after reconstitution; preservative-free.

Legal Classification:

Rx

Pharmacological Class for CYTOXAN INJECTION

Alkylating agent.

Manufacturer of CYTOXAN INJECTION

Bristol-Myers Squibb

Indications for CYTOXAN INJECTION

Adenocarcinoma of the ovary.

Other Indications for CYTOXAN INJECTION

Adult dose for CYTOXAN INJECTION

Initially 40–50mg/kg IV in divided doses over 2–5 days; or 10–15mg/kg IV every 7–10 days; or 3–5mg/kg IV twice weekly.

Children's dosing for CYTOXAN INJECTION

See literature.

Also:

Contraindications for CYTOXAN INJECTION

Severe bone marrow depression.

Warnings/Precautions for CYTOXAN INJECTION

Leukopenia. Thrombocytopenia. Tumor cell infiltration of bone marrow. Previous X-ray therapy or cytotoxic chemotherapy. Impaired renal or hepatic function. Infections. Adrenalectomy. General anesthesia within 10 days of therapy. Monitor hematologic profile (esp. neutrophils and platelets). Obtain urine sample (monitor for hemorrhagic cystitis); maintain adequate hydration. May interfere with wound healing. Elderly. Pregnancy (Cat.D). Nursing mothers: not recommended.

Interactions for CYTOXAN INJECTION

Potentiated by phenobarbital. Potentiates other myelosuppressives, radiotherapy, succinylcholine. May potentiate doxorubicin-induced cardiotoxicity.

Adverse Reactions for CYTOXAN INJECTION

GI upset, alopecia, leukopenia, infections, thrombocytopenia, anemia, hemorrhagic cystitis (discontinue if occurs), renal tubular necrosis, interstitial pulmonary fibrosis, gonadal toxicity (amenorrhea, infertility), anaphylactic reactions.

Notes for CYTOXAN INJECTION

Tabs formerly known under the brand name Cytoxan.

How is CYTOXAN INJECTION supplied?

Tabs—contact supplier
Single-use vial—1

Related Disease:

Cancer, breast
Cancer, ovarian
Leukemia
Lymphoma, malignant
Multiple myeloma
Mycosis fungoides~antineoplastics
Neuroblastoma

Related Resources

Adjuvant Radiochemotherapy Has Lasting Benefit in Gastric Cancer

May 18, 2012

Patients with gastric cancer who undergo resection show survival benefit 10 years later.

Fertility-Related Information Urgently Needed for Female Patients with Cancer

May 18, 2012

Young adult males and females with cancer receive vastly different amounts of fertility-related and fertility preservation information.

STAT3 Mutations ID'd in Rare Lymphoproliferative Disorder

May 18, 2012

Four specific mutations in SH2 domain seen in T-cell large granular lymphocytic leukemia.

Genetic Profiling Improves Prognosis of Uveal Melanoma

May 18, 2012

Gene expression profiling (GEP) and chromosomal analysis show prognostic value in patients with uveal melanoma.

Bisphosphonates Cut Skeletal Morbidity in Multiple Myeloma

May 18, 2012

Zoledronate superior to placebo or etidronate for improving overall survival.

ADRUCIL

Oncology > Colorectal and other GI cancers

Fluorouracil 50mg/mL; soln for IV inj.

AREDIA

Oncology > Leukemias, lymphomas, and other hematologic cancers

Pamidronate disodium 30mg; per vial; pwd for IV infusion after reconstitution; contains mannitol.

Fluoxymesterone

Oncology > Breast cancer

Fluoxymesterone 10mg; tabs.

HALAVEN

Oncology > Breast cancer

Eribulin mesylate 0.5mg/mL, soln for IV inj.

TAXOL

Oncology > Breast cancer

Paclitaxel 6mg/mL; soln for IV infusion after dilution; contains Cremophor EL (polyoxyethylated castor oil), dehydrated alcohol.

Oncology > Cytoprotective and supportive care agents

Bisphosphonates (eg, Aredia, Zometa) may inhibit the activation of cancer-associated proteins through the suppression of geranyl-geranylation and farnesylation or inhibit ...
more »

'Teachable Moments' for Smoking Cessation in Patients Diagnosed with Cancer Underutilized

Debra Hughes February 16, 2012

Less than one-fifth (18.1%) of healthcare providers reported high levels of confidence in their ability to counsel patients with cancer who smoke to quit smoking, a survey published in The Oncologist online February 14 has found.

Prognostic Potential of Cell Surface Markers and Pim Kinases in Multiple Myeloma

May 11, 2012

A look at the following clinical trial: Prognostic Potential of Cell Surface Markers and Pim Kinases in Multiple Myeloma

Clinical Study of PM01183 in Patients With Acute Leukemia

May 10, 2012

A look at the following clinical trial: Clinical Study of PM01183 in Patients With Acute Leukemia

Diuretics for Hypertension

December 30, 2011

Hypertension dosing regiment chart for loop, potassium-sparing, and thiazide-like diuretics.

Calcium Channel Blockers Chart

December 30, 2011

Calcium channel blockers (CCB) used to treat hypertension (HTN) including benzothiazepines, dihydropyridines, and diphenylalkylamines.

Beta Blockers

December 30, 2011

Beta blocker pharmacokinetic comparison chart.

Angiotensin-Converting Enzyme (ACE) Inhibitors for Hypertension

December 30, 2011

Angiotensin-Converting Enzyme (ACE) Inhibitors and ACEI Combination Therapy Hypertension Dosing Chart.

Angiotensin II Receptor Blocker (ARB) for Hypertension

December 30, 2011

Angiotensin II Receptor Blockers (ARB) and ARB Hypertension dosing.


© 2012 Haymarket Media, Inc.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions